VALENTIN FUSTER - CARDIOVASCULAR SYMPOSIUM IN BRAZIL

Main coordinator

Valentin Fuster

. Director, Mount Sinai Heart
. Director of the Zena and Michael A. Wiener Cardiovascular Institute
. Director the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health Richard Gorlin
. Heart Research Foundation Professor The Mount Sinai Medical Center

Faculty

.André D’àvila

Professor Associado da Mount Sinai School of Medicine em Nova York
. Co-Diretor do Servico de Arritmia do Hospital Mount Sinai de Nova York

Barry J. Maron - MD

. American College of Cardiology 2008 Distinguished Scientist Award
. Director of the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute Foundation

Blasé A. Carabello - MD, FACC

. Professor of Medicine - Baylor College of Medicine (Houston)

Clyde W Yancy - MD, MsC, FACC

. Chief, Division of Cardiology - Magerstadt Professor of Medicine - Northwestern University Feinberg School of Medicine (Chicago)

David Adams - MD, FACC

. Marie-Josee and Henry R. Kravis Professor
. Chairman, Department of Cardiothoracic Surgery - The Mount Sinai Medical Center, New York

Deepak L. Bhatt - MD, MPH, FACC

. Chief of Cardiology, VA Boston Healthcare System
. Director, Integrated Interventional Cardiovascular Program Brigham and Women's Hospital and VA Boston Healthcare System
. Senior Investigator, TIMI Study Group
. Associate Professor of Medicine, Harvard Medical School Boston, Massachusetts

Michael E. Farkouh - MD, MSc, FACC

. MD, University of Western Ontario / Mount Sinai Medical Center (Cardiology) / McMaster University (Epidemiology)
. M.D., University of Western Ontario / University of Toronto (Medicine) / Mayo Clinic (Medicine)
. Fellowship, General Medicine - McMaster University
. Fellowship, Cardiology - Mount Sinai Hospital
. Fellowship, Cardiology - McMaster University

Renu Virmani - MD, FACC, FAHA

. Clinical Professor, Department of Pathology at Georgetown University / University of Maryland-Baltimore / George Washington University / Vanderbilt University
. President and Medical Director of CVPath Institute
. honorary degree from the University of Antwerp, Belgium in 2008 and has also received honorary awards from European Society of Cardiology(2008) and EuroPCR (2006)

Samin K. Sharma - MD, MBBS, FACC

. Director of Interventional Cardiology and Cardiac Catheterization Laboratory
. Co-Director of The Zena and Michal A. Wiener Cardiovascular Institute
. Professor of Medicine

AGENDA

Saturday, May 19
9:00 a.m.	Registration Breakfast

Introductions
10:15 a.m.	Welcome and Introduction Dr. Fuster
Coronary Artery Disease — Challenges in 2012 Session I: New Discoveries in Athero-thrombogenesis Dr. Virmani, Presiding
10:30 a.m.	Two Evolving Trends – From Disease to Health and From Heart to Brain Three Evolving Tools - Imaging, Genetics & Tissue Regeneration Dr. Fuster
10:55 a.m.	Inflammation in Atherothrombosis A War of Defense vs. Betrayal, from Endothelium to Adventitia Dr. Virmani
11:20 a.m.	Atherothrombosis is a Systemic Disease The Fall of the Vulnerable Plaque Concept According to Imaging Dr. Fuster
11:45 a.m.	The Thrombotic Processes in Atherothrombosis A Subclinical and Clinical Chaos Dr. Virmani
12:10 p.m.	Panel Discussion Drs. Fuster and Virmani
12:45 p.m.	Lunch Break

Session II: Acute Coronary Syndromes Dr. Bhatt , Presiding
2:15 p.m.	STEMI and NON STEMI Clock Time Reperfusion Therapy and Evolving Ambulance Therapy Targeted at Myocardial Demand Dr. Bhatt
2:40 p.m.	The Evolving Science of Stents: New Challenges, New Materials, New Hopes Dr. Sharma
3:05 p.m.	Evolving Oral Agents for ACS – ADP Inhibitors, Thrombin Receptor Blockers, Fr Xa Inhibitors - Role of IT and Stakeholders (FDA, NHLBI, Industry) Dr. Bhatt
3:30p.m.	Panel Discussion Drs. Bhatt and Sharma
4:10 p.m.	Coffee Break

Session III: Chronic Coronary and Systemic Arterial Disease Challenges of Management and Prevention Dr.Farkouh, Presiding
4:30 p.m.	The Link Between Complex Coronary Disease with Carotid Disease Dr. Fuster
4:55 p.m.	Hypertension and Guidelines: Who to Believe? Dr.Farkouh
5:20 p.m.	Lipids and Guidelines: Regardless of the Patient or the Individual, Should we Always Try LDL-C<70 mg/dl Dr.Farkouh
5:45 p.m.	Evolving Challenge 1 - The Link Between Hypertension and Classical Risk Factors with Degenerative Brain Disease and Aging Dr. Fuster
6:10 p.m.	Evolving Challenge 2 - Renal Sympathetic Denervation Applications in Hypertension and Beyond Dr. D’Avila
6:35 p.m.	Evolving Challenge 3 - Promoting Cardiovascular Health Challenges Pre-School Children, the Adult Community and the Polypill Dr. Fuster
7:10 p.m.	Panel Discussion Drs. D’Avila, Fuster and Farkouh
7:30 p.m.	Adjournment

Sunday, May 20
7:15 a.m.	Breakfast

Cardio-Pulmonary and Electrical Failure 2012 Session IV: Systolic & Diastolic Heart Failure and Pulmonary Hypertension: Basis for Management Dr. Yancy, Presiding
8:00 a.m.	Evolving Diagnostic and Prognostic Imaging (MR, CT) of the Various Cardiomyopathies: Myocarditis, Dilated, Infiltrative (Amyloid, Sarcoid), Hypertrophic, Noncompaction Dr. Fuster
8:20 a.m.	State-of-the-Art Management of Systolic and Diastolic Heart Failure: BNP vs Symptom Standard Medical Guided Therapy Dr. Yancy
8:45 a.m.	Cardiac-Resynchronization Therapy for Systolic Heart Failure and Prevention of Events Dr. D’Avila
9:00 a.m.	Destination LVADs: A Rapidly-Evolving Alternative to Heart Transplantation Dr. Yancy
9:20 a.m.	State-of-the-Art Management of Pulmonary Hypertension: The Various Etiologies Dr. Yancy
9:40 a.m.	Panel Discussion Drs. D’Avila, Fuster and Yancy
10:10 a.m	Coffee Break

Session V: Rhythm Disorders, Contemporary and Future Topics of Focus Dr. D’Avila, Presiding
10:30 a.m.	Contemporary Management of Scar-related Ventricular Tachycardia Follow-up of the SMASH-VT Study Dr. D’Avila
10:45 a.m.	Atrial Fibrillation and the Quality of Life Key Platform for the Approach of Antithrombotics in CV Disease Dr. Fuster
11:10 a.m.	Atrial Fibrillation, Catheter Ablation: Increase in Safety and Benefit Dr. D’Avila
11:30 a.m.	Atrial Fibrillation, Role of Catheter Ablation and LAA Devices in the Prevention of Stroke Dr. D’Avila
11:45 a.m.	Panel Discussion Drs. D’Avila and Fuster
12:05 p.m.	Lunch Break

Valvular Heart Disease and Aorta — Challenges in 2012 Session VI: Understanding and Management of Aortic Valve Disease Dr. Carabello, Presiding
1:35 p.m.	Asymptomatic Severe Aortic Stenosis (AVA<0.75 cm2 or AVvel>4.5m/s) and LVH: What Are We Waiting For? Dr. Carabello
1:50 p.m.	The Best Aortic Prosthetic Valve Choice for a 45-year-old: Mechanic?, Pericardial (TAVI Later if Degenerates)?, Ross Procedure? Dr. Carabello
2:05 p.m.	Future of Transcatheter AVR: Just for the Elderly? The Interventionalist Perspective Dr. Sharma The Surgeon Perspective Dr. Adams
2:25 p.m.	State-of-the-Art Management of Aortic Regurgitation Dr. Carabello
2:40 p.m.	The Dilated Aorta and Its Consequences: New Understanding of the Basic Biology and Evolving Management Dr. Fuster

Session VII: Management of IHSS and Mitral Regurgitation Dr. Maron, Presiding
3:00 p.m.	Strech your legs and say "hello" to your neighbor
3:05 p.m.	State-of-the-Art Management of IHSS: Systolic & Diastolic Pharmacological Approach Septal Reduction (Alcohol, Myectomy) Dr. Maron
3:25 p.m.	It May Be Too Early or Too Late for Surgery in Severe Mitral Regurgitation Dr. Carabello
3:40 p.m.	Function and Anatomy of the Mitral Valve: Aiming for a Successful Repair What About the Present for Percutaneous Devices? Dr. Adams
4:05 p.m.	Panel Discussion Drs. Adams , Carabello, Fuster , Maron and Sharma
4:50 pm.	CLOSING LECTURE A Perspective of Genetics and Tissue Regeneration in 2012 Dr. Fuster
5:30p.m.	Program Adjournment